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Background: Millions of dollars are invested annually under the umbrella of national health systems strengthening.
Global health initiatives provide funding for low- and middle-income countries through disease-oriented
programmes while maintaining that the interventions simultaneously strengthen systems. However, it is as yet
unclear which, and to what extent, system-level interventions are being funded by these initiatives, nor is it clear
how much funding they allocate to disease-specific activities – through conventional ‘vertical-programming’
approach. Such funding can be channelled to one or more of the health system building blocks while targeting
disease(s) or explicitly to system-wide activities.
Methods: We operationalized the World Health Organization health system framework of the six building blocks to
conduct a detailed assessment of Global Fund health system investments. Our application of this framework
framework provides a comprehensive quantification of system-level interventions. We applied this systematically to
a random subset of 52 of the 139 grants funded in Round 8 of the Global Fund to Fight AIDS, Tuberculosis and
Malaria (totalling approximately US$1 billion).
Results: According to the analysis, 37% (US$ 362 million) of the Global Fund Round 8 funding was allocated to
health systems strengthening. Of that, 38% (US$ 139 million) was for generic system-level interventions, rather than
disease-specific system support. Around 82% of health systems strengthening funding (US$ 296 million) was
allocated to service delivery, human resources, and medicines & technology, and within each of these to two to
three interventions. Governance, financing, and information building blocks received relatively low funding.
Conclusions: This study shows that a substantial portion of Global Fund’s Round 8 funds was devoted to health
systems strengthening. Dramatic skewing among the health system building blocks suggests opportunities for
more balanced investments with regard to governance, financing, and information system related interventions.
There is also a need for agreement, by researchers, recipients, and donors, on keystone interventions that have the
greatest system-level impacts for the cost-effective use of funds. Effective health system strengthening depends on
inter-agency collaboration and country commitment along with concerted partnership among all the stakeholders
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 37% (US$ 362 million) of funding in Round 8 of the
Global Fund to Fight AIDS, Tuberculosis and
Malaria was for health system strengthening.
 Of the HSS funding, 38% (US$ 139 million) was for
system-level interventions while 62% (US$ 223
million) was dedicated to disease-specific system
strengthening activities.
 Around 82% (US$ 296 million) of health systems
strengthening funding in Round 8 was dedicated to
service delivery, human resources, and medicines.
Background
In less than 20 years approximately 100 global health initia-
tives (GHIs) have been created to meet the Millennium
Development Goals (MDGs). These GHIs, often established
as public-private partnerships, have leveraged and
mobilised unprecedented levels of funding channelled
through governments and civil society organizations
for specific diseases and targeted interventions [1,2].
At country level this has led to a fragmentation of
service delivery with unpredictable effects on health
systems [3-7]. Investment in health system strength-
ening (HSS) was proposed to mitigate adverse effects
of the increasingly complex funding flows [3,8-13],
address health system bottlenecks, and accelerate pro-
gress towards the MDGs [8,10,14-17].
The Global Fund to Fight AIDS, Tuberculosis and
Malaria (Global Fund), the Global Alliance for Vaccines
and Immunisation (GAVI), and the President’s Emergency
Plan for AIDS Relief (PEPFAR), for example, channel
funds for HSS based on the World Health Organization
(WHO) health systems framework that identifies ‘six
building blocks’ [7,18-21]: governance, financing, in-
formation, human resources, medicines and technol-
ogy, and service delivery [21,22]. This framework has
been discussed extensively and many derivatives have
been developed for describing and studying health
systems [2,7,8,18,23-30]. Because GHIs that support
strengthening of recipient systems often use the WHO
framework as the foundation of their HSS programs, the
building blocks can be useful for cross-analysis of donor
funding.
Our study, which aimed to quantify and categorize the
Global Fund’s HSS funding, had two objectives: 1) to
propose an adapted, operational framework with which
to classify GHIs’ financial investments in HSS, and 2) to
apply it to the Global Fund.
Although there is a body of literature on disease-specific
investments by GHIs and their impact [8,31-35], there are
relatively few publications on HSS-specific funding. Mean-
while, there has been substantial criticism that the Global
Fund and other GHIs allocate insufficient resources toHSS [26,36-39]. This is likely a reflection of the debate
within these global initiatives on the level of funding that
should be allocated to HSS and whether the funding
should be through disease-specific interventions or
through more generic investments in health systems to
benefit target diseases and beyond [18,40]. The Global
Fund allows investment in health systems both through
disease-specific funding and through general health
system strengthening activities [7,41]. Over the years the
Global Fund has used a range of approaches to fund HSS
activities. For example, in 2006 there was a specific call for
HSS grants in Round 5 [42], and ‘cross-cutting’ health sys-
tem interventions could be funded in subsequent Rounds
[42,43]. Though the Global Fund provides an overview of
their HSS financing [44], few studies have attempted to es-
timate the proportion of funding specifically allocated to
health systems strengthening through disease-specific
and/or to more generic (cross-cutting) interventions [17].
In 2010, the Global Fund provided approximately two
thirds of international funding for fighting malaria and
tuberculosis (TB) and nearly a quarter of funding for
AIDS; claiming also to be the “largest multi-lateral chan-
nel for efforts to strengthen health systems” [45]. In
2011 the Global Fund provided 10% of total develop-
ment assistance for health [13]. On 1 March 2008, the
Global Fund launched Round 8. By 8 November 2008, 140
grants were approved for 65 low- and middle-income
countries with a total value of approximately $2.5 billion
for Phase I (almost twice as large as earlier Rounds). The
largest single grant in Round 8 was awarded to Ethiopia
for malaria with a value of approximately $133 million
(5.4% of overall), and the smallest grant, worth approxi-
mately $532 000, was awarded to Tunisia for TB. Overall,
Nigeria received the largest total amount of $340 million
(~14% of the total for Round 8) through four grants –
three dedicated to malaria and one dedicated to HSS.
When adapting the existing WHO health system frame-
work [21], we considered other examples developed by
Biesma et al. [8], Samb et al. [2], and Shakarishvili et al.
[17]. The framework by Biesma et al. includes assessment
of the Governance, Human Resources, and Financing
building blocks, but not for activities in the Medicines and
Technologies, the Service Delivery, or the Information
subsystems - though monitoring and evaluation (M&E) is
included [8]. The framework by Samb et al. is more com-
prehensive and is based on the WHO building blocks, but
it was developed for assessing outcomes/effects rather
than investment amounts [2]. The framework developed
by Shakarishvili et al. was developed at the Global Fund
specifically for tracking HSS investments using four do-
mains of Stewardship and Governance, Health Services,
Financing, and Monitoring and Evaluation (including
health information systems) [17]. We built upon these
frameworks to elaborate a classification mirroring the
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building blocks framework when requesting funds from
the Global Fund.
Methods
We systematically reviewed the grants funded by the
Global Fund in Round 8 – the largest Round totalling
approximately $2.5 billion for Phase I. We used a frame-
work (See Table 1 for abridged version; Additional file 1:
Table S1 for full version) that draws on the WHO six
building blocks [21], frameworks developed by Biesma
et al., Samb et al., and Shakarishvili et al., the WHO’s
Framework for Action, Fixing Health Systems, and Sys-
tems Thinking by de Savigny and Adam, and discussions
with experts in the respective fields [2,8-10,16,17,21].Table 1 HSS funding assessment framework (abridged)
Building Block Function Intervention
Governance Capacity building See Additional
file 1: Table S1
Harmonisation
Sector integration
Decentralisation
National health strategy
development
Coordination
Financing Maximise social protection
Improve resource effectiveness
Patient and/or provider incentives
Financial management
transparency
Information Health information systems
strengthening
Strategies to increase
evidence-based planning
Increase accessibility of
information
Human resources Support for pre-service training
Support for in-service health
workforce
Medicines and
technology
Support for rational use of
essential medicines
Improve management of essential
medicines
Affordable, quality essential drugs
programme
Health service supplies
(non-consumables)
Service delivery Infrastructure
Measures to increase
coverage - supply
Measures to increase
coverage - demandThe adapted framework we propose provides a compre-
hensive (but not exhaustive) framing of system-level in-
terventions requested by countries and funded by the
Global Fund. Such a framework is meant to serve as a
tool for cataloguing and mapping the HSS content and
funding of any Global Fund proposal. Besides determin-
ing the monetary amount invested in each building
block, analysis with this framework serves to determine
whether or not health system strengthening is restricted
to disease programmes or is more generic.
The first tier in the HSS Funding Assessment Frame-
work is comprised of the WHO-defined health system
building blocks. The second tier contains relevant func-
tions of each building block, and at the third tier – the
deepest level of resolution – describes system-level inter-
ventions (only the first two tiers are shown in Table 1).
In the rare occasion that a budgeted activity (i.e. action
having its own budget line in the detailed budgets pro-
vided to the Global Fund by the Principal Recipient)
could not be classified at the intervention level, it was
classified at the next highest level of resolution, either
the second or first tier.
All grant materials were collated from the Global
Fund internal database, with the consent of the Strategy,
Performance, and Evaluation Cluster at the Global Fund.
Overall 139 grants were funded in Round 8 including 52
grants dedicated to HIV/AIDS, 34 to tuberculosis, 46 to
malaria, and 7 to HSS.
Of the 139 grants funded in Round 8, 27 were ex-
cluded from classification due to language (submitted in
either French or Spanish) and budgets from 41 grants
were unavailable at the time of analysis. We selected 52
grants from the remaining 71 grants; this sub-set is rep-
resentative of the Round 8 grant portfolio in terms of re-
gion and disease-component (using chi-squared analysis;
see Additional file 1: Tables S2, S3, and S4). The sub-set
of grants is also representative of the Round 8 portfolio
in terms of dollar-value. The median dollar (US$) value
of grant agreements in Round 8 is US$8.5 million with
an Interquartile Range (IQR) of US$22.9 - 4.4 million.
The median dollar value of the study subset is US$9.8
million with an IQR of US$23.3 - 4.9 million.
Additional file 1: Table S1 of the Signed Grant Agree-
ment, which outlines key activities, was analysed to es-
tablish the aims of each grant; the SGA’s main body of
text was consulted for clarification when necessary. The
Final Detailed Budget for Phase I, included in the grant
agreement, provided to the Global Fund by the Principal
Recipient, was reorganized to fit a standardised template
in Microsoft Excel to remove any inconsistencies in for-
matting and, therefore, facilitate comparison. For every
grant the grant number, region, agreed amount, and dis-
ease component, as well as the detailed description of
each activity, Cost Category, and the Service Delivery
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cluded for accurate classification. Budget lines dedicated
to activities for Phase II were excluded. Our calculations
are based on the Sum Total found in the grant budget.
Upon standardization of the Final Detailed Budget in
Microsoft Excel, three analysis-specific columns were
added for classification using the HSS Funding Assess-
ment Framework, tagging the activity as disease-specific
or system-wide, and categorizing non-HSS activities.
Each cell in the ‘HSS Classification’ column contained a
drop-down menu with the HSS Funding Assessment
Framework, and each cell in the ‘Disease-Specificity’ col-
umn contained a drop-down menu for differentiating
between disease-specific and system-level classification.
Each budget was then classified line-by-line with these
two categories. If a budget line was deemed “Non-HSS”,
it was tagged and classified using the drop-down menu
containing “Grant Management”, “Salary / Per Diem”,
“Commodities, Diagnostics, and Drugs”, or “Other”. A
‘Comments’ column was used for acronym definitions
and notes or rationale about classification. For example,
the activities supporting the development of a Malaria
Surveillance Database in Swaziland were categorized as
burden of disease data collection rather than design and
development of HMIS. The corresponding ‘Comments’
column contained a note explaining why it was not clas-
sified as HMIS strengthening: “data is not routine nor is
it gathered at the health facility level”.
In summary, each activity was examined using the
process outlined in Figure 1.
An activity was considered “disease-specific” if it
followed a conventional ‘vertical-programming’ approach -
targeting system support within one or more buildingUse Exclus
criteria to
Is activ
Classify activity using HSS Funding 
Assessment Framework
Does the activity target a disease?
Disease-specific System-wi
Yes
Yes No
Figure 1 Decision tree used in classification of each budgeted activityblocks specifically for AIDS, tuberculosis, and/or mal-
aria. An activity was deemed “system-wide” if it expli-
citly targeted any building block, either individually or
collectively, without explicitly targeting one of the three
diseases [10].
Exclusion/Inclusion criteria were developed to distin-
guish between HSS and Non-HSS budgeted activities
(see Additional file 1: Table S5). Stand-alone routine
activities, such as salaries, meetings, rent, and ongoing
operating costs, used to maintain rather than strengthen
the health system were excluded. Although these are
important activities fundamental to any health system,
they do not improve or reinforce how the system func-
tions nor do they alter the effectiveness or efficiency of
the health system. If, however, they were nested within
an HSS activity, then they were classified accordingly.
For example, Swaziland’s budget-line “Technical assist-
ance – Malaria Surveillance Database upgrade” that was
nested within the activity “Development of Malaria
Surveillance Database” was labelled as disease-specific
HSS. Funding for training or support for persons working
outside of the health system, i.e. anyone whose primary in-
tent is anything other than improving or maintaining
health (ex. social workers, police officers, etc.) was also
excluded. The support of international technical assistance
was also excluded because funding for temporary inter-
national consultants accrues not to local staff or the health
system budget. Incentives for patients framed as patient
support were excluded because the target is not the sys-
tem but rather the patient.
Upon completing the classification of the 7,261
budgeted activities, the data were filtered and tabulated
by region, building block, function, intervention, disease-ion / Inclusion 
 determine: 
ity HSS?
Classify activity as Grant 
Management; Salary / Per Diem; 
Commodities, Diagnostics, & 
Drugs; or Other
de
No
.
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currencies were standardized to USD. Original grant
agreements signed using the Euro (€) were converted to
USD based on the start date of the grant agreement [46].
Start dates ranged from 1 July 2009 to 1 October 2010
(Additional file 1: Table S6 for dates and corresponding
exchange rates).
Results
Around 37% of the activities in our sample (approxi-
mately US$362 million) qualified as health system
strengthening interventions according to the HSS
Funding Assessment Framework. Of these HSS activities
38% (~US$139 million) were categorized as system-wide
strengthening whereas 62% (~US$223 million) were
considered to be disease-specific HSS activities (with an
overall proportion of 14% (US$ 139 million) and 23%
(US$ 223 million); respectively (Figure 2). Of the Non-
HSS activities Commodities, Diagnostics, and Drugs re-
ceived the most funding at 36% (~US$358 million) of
the total.
Nearly one-third of the funds budgeted for HSS were
dedicated to Service Delivery, whereas the Governance,
Financing, and Information building blocks comprise
under one-quarter of the funds (Figure 3).
Table 2 provides higher resolution to the division of
resource allocation within each building block. The Gov-
ernance, Financing, and Human Resources building
blocks are heavily skewed towards a primary function,
but the Information, Service Delivery, and Medicines
and Technology building blocks have benefited from
more even investments across multiple functions.Figure 2 Resource allocation profile of HSS and Non-HSS activities. Su
million; System-wide HSS $184 million; Grant Management $66 million; Sala
million; and Unclassified $129 million.Governance
The Governance building block received 5% (~$19 mil-
lion USD) of the HSS resources. Over half the funds
dedicated to the Governance building block was for ‘sec-
tor integration’, with a small amount (~1%, combined)
for ‘coordination’ and ‘harmonization’ functions.
Activities devoted to collaboration with civil society
account for approximately 87% (US$ 9 million) of the
funding dedicated to ‘sector integration’ (and therefore al-
most 48% of the funds for Governance; just over US$9 mil-
lion). Within the Governance building block all the funds
dedicated to training on sector integration, decentralization
of management/resource control, and measures to increase
accountability/transparency were implemented through
activities that were deemed system-wide. All activities for
collaboration between Ministries and the decentralization
of leadership/ownership were disease-specific. Examples
include “[Ministry of Health], [Ministry of Youth and
Sports], [Ministry of Education] and NGO staff would
do outreach to all vulnerable youths populations and
provide them with HIV/AIDS preventive services” in
Mauritius and “Leadership and coordination of county-
level leading groups for TB control among the migrant
population” in China; respectively.
Financing
Around one percent (~US$4 million) of Round 8 re-
sources were allocated to the Financing building block,
and of this more than 93% (~US$3.7 million) was dedi-
cated to ‘patient and/or provider incentives.’ Support for
‘financial management transparency’ and ‘maximizing social
protection’ received negligible funding, and interventionsb-set absolute values- Overall $1.1 billion; Disease-specific HSS $223
ry / Per Diem $67 million; Commodities, Diagnostics, and Drugs $358
Figure 3 Resource allocation profile of WHO building blocks. Sub-set absolute values- Total HSS $463 million; Governance $19 million;
Financing $4 million; Information $44 million; Human Resources $82 million; Medicines and Technology $101 million; and Service Delivery
$112 million.
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function received approximately 6% (US$ 237 000). Of the
six building blocks Financing had the greatest skewing for
few interventions. There was greater heterogeneity in
system-wide interventions than in disease-specific. All funds
classified as disease-specific fell within ‘patient and/or pro-
vider incentives’ and ‘financial management transparency’
while all four functions were supported (albeit minimally)
with system-wide interventions.
Information
Global Fund Round 8 spending on the Information
building block was around 12% (~US$44 million); of this,
55% (~US$24 million) was dedicated to the function
‘health information system strengthening’. All funds for
introducing an electronic records system were through
system-wide activities such as “develop and implement
electronic medical record systems in 3 central hospitals”
in Mozambique and Bulgaria’s “online data base with
the health facilities and professionals trained and in-
volved in [Planning, Public Policy, and Management]”.
The dominant interventions were: training/compensation
of staff (24%; US$ 10 million) and M&E strengthening
(25%; US$ 9 million). Harmonization with the national
health information system (HIS), design and develop-
ment of health management information system, and
standardization/rationalization of indicators – all important
interventions – received in combination less than 6% (US$
805 000) of the funds allocated to Information buildingblock. The resources dedicated to design and development
of HMIS and the standardization/rationalization of indi-
cators all fell under system-wide spending. Examples
include Nigeria’s “strengthen routine data generation
and flow from public/private facilities and community
based health providers for the National Health
Management Information System” and a “workshop to
develop a comprehensive list of indicators for reporting
on the health system” in Sudan.
Human resources
Approximately 23% (~US$82 million) of HSS spending
was dedicated to Human Resources. Around 97% (~US
$80 million) of Human Resources investments were ded-
icated to ‘support for in-service workforce’. The top
three interventions in the Human Resources building
block were continuing education/on-the-job training,
leadership and management capacity building, and
improvement of feedback and supervision (56% - US
$ 46 million, 27% - US$ 23 million, and 10% - US$ 8
million; respectively). Task shifting interventions such
as “malaria control work load analysis,” and support
for referral system received fewer funds and were
funded entirely for disease-specific purposes whereas
Salary/Per Diems (Non-HSS) received 7% of support over-
all. All funds dedicated to supporting training institutions
was for system-wide activity. Overall, 66% (~US$54 mil-
lion) of support for the Human Resources building block
was for disease-specific interventions.
Table 2 Proportion of funding per WHO building block
Health system building
block interventions
% of spending within
building block
Disease-specific System-wide Total
Governance
Sector integration 67 40 55
Decentralisation 5 21 12
Capacity building 1 25 11
National health strategy
development
14 5 10
Coordination 9 3 6
Harmonisation 5 3 4
Financing
Patient and/or
provider incentives
99 86 93
Improve resource
effectiveness
0 13 6
Financial management
transparency
1 0 1
Maximise social protection 0 1 0
Information
Health information systems
strengthening
39 74 55
Strategies to increase
evidence-based planning
54 18 37
Increase accessibility
of information
7 3 5
Human Resources
Support for in-service health
workforce
99 93 97
Support for pre-service health
workforce
1 7 3
Medicines and Technology
Health service supplies
(non-consumables)
25 90 54
Improve mgmt of essential
medicines
55 9 34
Support for rational use
of essential medicines
19 1 11
Affordable, quality EDP 1 1 1
Service Delivery
Infrastructure 38 74 49
Measures to increase
coverage - demand
55 19 44
Measures to increase
coverage - supply
7 6 7
EDP: Essential drugs programme.
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Approximately 28% (~US$101 million) of HSS spend-
ing was dedicated to Medicines and Technology. Just
over 50% (US$ 54 million) of this was for the
provision/maintenance of equipment and close to 26%was for equipping central and regional medicine de-
pots (~US$54 million and ~ US$26 million; respect-
ively). Both of these activities made it in the top ten
of total expenditure overall. Overall, the provision/
maintenance of equipment was the largest system-wide
expenditure. Strengthening of supply chain management
received 8% (US$ 8 million) of the support provided to
Medicines and Technology, and of this 98% (US$ 7.9 mil-
lion) was dedicated to disease-specific interventions, for
example, to “improve supply chain management for HIV
test kits, and other medical supplies necessary to conduct
HIV test and counselling at all health care facilities offer-
ing the services” in Zimbabwe and “logistic for storing and
distribution [insecticide treated nets] to target municipal-
ities” in Brazil. Strengthening procurement systems was
entirely through system-wide measures, though this func-
tion represents less than 1% (US$ 472 000) of the building
block.
Service delivery
Over 30% (~US$112 million) of Global Fund’s HSS re-
sources were dedicated to Service Delivery. Within this,
49% (US$ 55 million) was dedicated to ‘infrastructure’
and 44% (US$ 49 million) to ‘measures to increase
coverage’ from the demand side (~US$55 million and ~
$49 million). Of the ‘measures to increase coverage’ from
the supply side, 25% (US$ 2 million) was dedicated to
disease-specific standardization of care; “establish sys-
tems for early infant diagnosis for all HIV exposed ba-
bies” in Ghana, for example. The three most common
interventions for ‘infrastructure’ were provision/mainten-
ance of transportation, maintenance of institutions/dis-
pensaries, and support for waste management systems.
Very little funding was dedicated to capital construction
or maintenance of storage facilities.
Most of the funding dedicated to ‘measures to increase
coverage - demand” was channelled through activities
for social marketing to increase awareness. A much
smaller share was for alignment of services with cultural
norms. Social marketing to increase awareness is in the
top ten in terms of overall funding. Approximately 99%
(US$ 31 million) of the financing for social marketing
had disease-specific priorities. Social marketing to in-
crease awareness about primary health care services or
on general health was negligible.
Discussion
The HSS Funding Assessment Framework used for this
study was developed to track, compare, and understand
financial inputs for health systems by global health ini-
tiatives and applied to the Global Fund Round 8 [16,38].
Activities were classified using signed Phase I budgets,
not effective disbursements or expenditure. Most pro-
grams do not manage to absorb the entire budget, but
Warren et al. Globalization and Health 2013, 9:30 Page 8 of 14
http://www.globalizationandhealth.com/content/9/1/30budgets represent perceived priorities of the Principle
Recipient. Each budgeted activity was classified along a
building block rather than expected downstream out-
comes; due to the non-linear interactions between build-
ing blocks one cannot attribute a given input to a given
output. For example, Bulgaria’s “Training Roma commu-
nity workers in outreach work and needs assessment of cli-
ents” was classified as ‘continuing education/on-the-job
training’ and cannot directly credited to a given outcome
such as access, equity, or quality.
Exclusion/Inclusion criteria were developed before the
analysis during the reading of randomly selected Signed
Grant Agreements and Original Proposals from Round 8
(see Additional file 1: Table S5). The inclusion criteria
served more as a reminder for classifying a few fre-
quently budgeted activities; the HSS Funding Assess-
ment Framework (see Additional file 1: Table S1) is
fairly comprehensive, and therefore obviated the need to
establish extensive inclusion criteria.
One limitation to this first application study is the lack
of a validity test for either the framework or the Exclusion/
Inclusion criteria. Only one person reviewed the grants
and classified activities. This retrospective analysis could
be strengthened if there were two reviewers. The budgets
are reviewed by the Global Fund before approval, so overall
they are quite clear, but it could be useful if the reviewers
were in contact with Principle Recipients to discuss and
clarify specific budget lines if need be. Ideally, in order to
avoid placing any further strain on Recipients and further
fragmenting reporting systems such tracking/analyses
could be incorporated into routine auditing. Guidelines
could be developed for recipients and they could classify
each activity themselves when designing the budget.
There are other inherent limitations to this study
based on the Global Fund documents used. However
our overall estimate of HSS support in Round 8 (37%)
concurs with that of the GF’s own assessment (cited on
website [44] on 24 January 2011 at the time of analysis).
The HSS Funding Assessment Framework could also
potentially be applied to other GHIs supporting HSS
activities, for example the GAVI Alliance and the PEPFAR,
depending on the resolution of approved budgets. The
GAVI Alliance uses HSS as a means to reach their
immunization-specific objectives [1,47]. This framework
could capture the landscape of their investments as they
utilize the WHO definition for health system and its four
key functions [48]. It uses the WHO six building blocks,
however, they are rephrased to fit into immunization pro-
gram functions [38].
PEPFAR, is primarily interested in HSS activities as a
means for ensuring a sustainable response to the HIV/
AIDS pandemic. Its primary HSS activities include task
shifting; and training, retaining, and creating support
systems for health workers. Unfortunately, PEPFARengages in bilateral partnerships that often circumvent
the recipient health sector’s existing structures [49]. It is
unclear what explicit HSS approach or framework
PEPFAR uses; they avoid much of the HSS rhetoric in
the literature they produce [50]. Thus, the use of such a
framework could be particularly useful in elucidating
specific PEPFAR HSS investments.
Governance
Arguably, governance is the cornerstone of a health sys-
tem, as it includes the formal and informal players that
define and enforce rules needed for the system to per-
form its key functions of promoting and protecting the
health of its population [51,52]. Recently frameworks
have been developed specifically to assess governance in
health systems [53,54]. Though they include activities
outside the scope of GHIs, these more exhaustive frame-
works include many relevant principles: transparency,
accountability, equity and inclusiveness, provision of in-
formation, standards, and regulations, as well as the im-
portance of relevant stakeholder participation, including
civil society. In general, there is a gap in the literature
about specific governance interventions in the health
system. Therefore there are no concrete guidelines for
strengthening governance mechanisms.
Overall, collaboration with civil society is a distinguishing
feature of GHIs, and the Global Fund in particular, so it is
not surprising to find direct evidence of heavily weighted
investment in civil society organizations. There was
support for a wide range of activities to engage civil
society. Lesotho prioritized sustained institutional cap-
acity, sector-wide representation of civil society con-
stituencies, participation in regional and continental
civil society networks, and outlining laws and policies
needed for civil society strengthening. Mauritius fo-
cused specifically on engaging prison staff for devel-
oping national protocols and guidelines for needle
exchange and condom distribution. Tajikistan requested
funds for community outreach strategies based on multi-
stakeholder round table discussions.
Although there is evidence that the voice of the
civil society component of the Country Coordinating
Mechanism is minimized in the outline of program prior-
ities [55], it appears that the Global Fund is dedicated to
increasing outlets for civil society engagement. Re-
searchers have found there to be both positive and nega-
tive effects of high levels of civil society engagement.
Civil society has played an important role in expanding
service delivery to include marginalized groups, monitor-
ing good governance and increasing responsiveness to
community health priorities, advocating for evidence-
based health policy reforms, and providing guidance for
patient follow-up and outreach services [56-62]. However,
civil society organizations are sometimes considered to
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legitimacy [63,64].
Given the allegations of corruption uncovered by the
Global Fund’s Inspector General in some Principal
Recipients and sub-recipients, we note a surprisingly
low proportion of funds dedicated to measures aimed
at increasing accountability/transparency (~1% -US$ 190
000 - of funds allocated to Governance). Only three grants
contained such interventions. Liberia budgeted for moni-
toring and supervision support; Lesotho proposed to es-
tablish a Secretariat within an HIV/AIDS cross-sectoral
program, and Serbia sought to develop guidelines for
supervision within their HIV/AIDS program. It would be
encouraging to see increased measures of accountability/
transparency accompany activities that involve collabor-
ation between the Principal Recipient and external forces
such as civil society, various Ministries, and other sectors.
It is also notable that minimal funding is allocated to
the ‘harmonization’ function (approximately 4% (US$
773 000) considering the evidence of increased coordin-
ation and alignment between some GHIs and recipient
governments / country-level sectors [35]. Harmonization
between donors and governmental agendas is important
for ensuring that recipient priorities are being addressed.
It could be that over time the Global Fund aligns with
national priorities through continued efforts to collabor-
ate with civil society who in turn advocate at the na-
tional level.
One budgeted activity that could only be resolved
at the second-tier of the HSS Funding Assessment
Framework, but is a good example of a system-wide
activity in the Governance building block, was found
in a grant from Tajikistan. The activity was described as,
“advocacy and training on HSS concepts and approaches
to national and international stakeholders.” Creative and
ambitious activities such as this may increase the likeli-
hood of sustainability of any program, disease-specific or
otherwise.
Financing
The Financing building block received only 1% of the in-
vestments in HSS. ‘Patient and/or provider incentives’
make up the vast majority of this 1% (at 93% (US$ 4 mil-
lion) of the Financing building block). This function,
which serves to increase patient adherence and health
worker compliance thereby overcoming inequities in
affordability and distribution of health services, includes
interventions such as conditional cash transfers, pay-for-
performance schemes, and remuneration for geographic-
ally isolated service providers. Specific examples include
incentive cards for high-risk groups to receive Voluntary
Testing and Counseling services, support for bednet vou-
cher schemes, and incentives for community workers,
healthcare providers, and laboratory technicians.Inevitably there were examples that could only be as-
cribed to the second-tier. An example that fell within
this function but did not fall specifically within the
boundaries of the listed interventions is in a Liberian
grant, “Facilities quarterly performance award”. Almost
half of the funds dedicated to ‘patient and/or provider
incentives’ were earmarked for remuneration of geo-
graphically isolated service providers (46%). Remuner-
ation is one of the most fundamental influences on
retention and redeployment of health workers to rural
areas [65-67].
‘Improving resource effectiveness’ received 6% (US$
237 000) of the funds directed towards strengthening
the Financing building block. This function includes the
use of evidence to plan and budget, standardization of
service provider payment methods, and the support of
Sector-Wide Approach (SWAp) schemes. The only activ-
ities that were funded in this function fell outside the
boundaries of the aforementioned interventions. One such
example is from a Sudanese grant, “Workshop to inform
the review of alternate resource generation mechanisms”.
There is negligible funding provided to ‘maximizing
social protection’ or ‘financial management transpar-
ency’. Sufficient funding dedicated to ‘maximizing social
protection’ could mitigate the negative effects of multiple
financing arrangements on national health financing sys-
tem. This fragmentation of financing makes resource
pooling virtually impossible [68]. There is a clear need
to support interventions to improve ‘financial manage-
ment transparency’. If there is such little transparency in
the financial management of diligently monitored exter-
nal funds, then the national health financing system is
likely to be even more convoluted and leaky.
Information
If managed improperly, GHIs can be the cause of mul-
tiple potential burdens on the national HIS of recipient
countries. For example, performance-based funding can
lead to the distortion of information/selective reporting
and separate disease-specific information systems [69,70].
There is a growing effort of donors to harmonize and align
monitoring and evaluation efforts with one another
[69-73], but GHIs still demand special reporting [74].
For example, in Cambodia, Cameroon, and Uganda,
the Global Fund’s project-related monitoring tools re-
portedly undermined the national programs [71,75].
The parallel M&E systems set up by GHIs drain time,
money, and workers from the existing system though
additional reporting requirements [3,74] and contrib-
ute to avoidable transaction costs [76]. As awareness
of these detrimental effects has increased, efforts of
GHIs to match and standardize national HIS indica-
tors have improved [71,75-79]. There is also evidence
that although GHIs are beginning to invest more in
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reporting, in the development of HIS, and in technical as-
sistance, they are still neglecting to strengthen the existing
national HIS [80,81].
Although the greatest portion of Information funds
was dedicated to ‘health information system strengthen-
ing,’ per se, there was little variation in interventions
supported within the building block. Only five activities
were funded in three countries. Liberia received funds to
expand the data collection database management and
reporting system; Nigeria was funded to advocate to
local government authorities and community leaders on
the importance of data generation, feedback and use;
and Sudan proposed to develop a data dictionary and
design a survey for collecting data on the health system’s
performance.
Human resources
The Human Resources building block received around
23% (US$ 82 million) of the total funds dedicated to
HSS in Round 8. A strong and appropriately distrib-
uted health workforce is a critical factor for expanding
service coverage to improve population health [82,83].
The WHO estimates that there is a gap of close to 4 mil-
lion trained healthcare workers, and Africa alone needs
about 1.5 million workers trained to compensate for the
deficit [84].
Around 56% (US$ 46 million) of funds for Human
Resources were for continuing education/on-the-job
training and 27% (US$ 23 million) to leadership and
management capacity building. 10% (US$ 8 million) was
dedicated to the improvement and feedback of supervi-
sion. All three of these interventions are ‘support for
in-service health workforce’. Continuing education/on-
the-job training, of course, included training for specific
procedures and training of counsellors, etc., but other
examples included training staff on cohort studies and
procedures, training for advocacy, training in nutritional
advice, training of trainers, and training of primary
health care workers for quantification and forecasting
for malaria.
Imbalance in investments for training for the in-
service workforce is not unique to the Global Fund as
supported in the primary literature. GHIs tend to focus
on training in-service workers on technical areas of
disease-specific concern with less attention dedicated to
system-wide topics such as management and capacity
building [85,86]. Few GHI resources have been allocated
for pre-service support or other measures that would
increase the absolute numbers of health workers [36].
Developing strong and comprehensive curricula for
training pre-service workers will likely lead to strong
care providers, but there then must be systems in
place to retain these well-trained workers [87]. Theseinterventions are interdependent and simultaneously
strengthening more than one function will have syner-
gistic effects.
One example of an activity that was classified as ‘sup-
port for pre-service training’, but did not fall within the
boundaries of any of the interventions relates to a grant in
Afghanistan which allocated resources to “development of
a system for conducting examinations and accreditation of
the students”. There were also some interesting activities
classified as ‘support for in-service worker health work-
force’: 1) development of a “capacity needs assessment
and strategic plan for the development of medical associa-
tions”, and 2) “contribution to HR retentions scheme”
(Liberia and Zimbabwe, respectively).
Medicines and technology
The Medicines and Technology building block deals
largely with the accessibility, affordability, acceptability,
and availability of medicines [88]. Over the past decade
access to medicines for HIV/AIDS, tuberculosis, and
malaria has improved in several countries, but availabil-
ity and affordability of other essential medicines remains
inadequate [89]. Besides insufficient medicine supply
chain and procurement systems, many country health
systems are burdened by irrational use of available medi-
cines, medical supplies, and laboratory reagents [90]. A
great deal of financial support is channelled to the Medi-
cines and Technology building block, but this funding
should also address country-specific weaknesses relating
to access of essential medicines and technologies when
designing a plan of action [91].
As with some of the other building blocks, the magni-
fied resolution provided by the analysis using the HSS
Funding Assessment Framework shows the majority of
funds dedicated to Medicines and Technology are con-
centrated in few activities- 53% (US$ 54 million) of the
building block’s support was allocated to the provision/
maintenance of equipment and 26% was to equip
central and regional depots. Although all of the activ-
ities found in the HSS Funding Assessment Framework
are important, some have potentially greater effects on the
system.
Of all the interventions nested within Medicines and
Technology, it is vital that the strengthening of supply
chain management and procurement systems is not
overlooked [92]. Functioning supply chain and pro-
curement systems are critical for equitable availability,
affordability, and acceptability of essential medicines
[93] Examples of recipient prioritization of include
the Solomon Islands’ request for funds to assess the
second-level medical stores’ capacities, risks, needs, gaps,
and strengthening requirements; Sudan’s development of
a framework for synergistic operation of the Central
Medical Stores and donor-funded procurement; and
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warehouses based on capacity needs in Liberia.
Service delivery
The ‘infrastructure’ function received approximately half
of Service Delivery funds, and maintenance of institu-
tions/dispensaries was the highest funded intervention at
20% (US$ 23 million) of total Service Delivery spending.
Maintenance of storage facilities and capital construction
were not well-supported (at 5% (US$ 3 million) and 3%
(US$ 2 million); respectively). Perhaps there was more
money dedicated to the maintenance of storage facilities
than the analysis shows; the activities could have been
nested within support for institutions/dispensaries. The
level of detail in the description of each activity varied,
and finer differences, such as the target of maintenance,
could have easily been left out of the description. Capital
construction is an unlikely investment for agencies such
as the Global Fund due to the lengthy, resource consum-
ing processes it involves. Every three years the Global
Fund meets with international donors for the replenish-
ment of its funds. Therefore, it seems likely that it would
prefer to invest in shorter-term activities that have more
measurable results. Maintenance of institutions/dispens-
aries could serve as a substitute for capital construction.
‘Measures to increase coverage’ from the supply side
are severely under-represented at 7% (US$ 7 million) of
the building block. This includes interventions such as
the standardization of care, integration of services, and
support for a referral system. Of these three, the integra-
tion of services received more attention which is in line
with discussions on vertical programming and HSS
[6,25,28,32,73,74,94]. Despite the attention of global re-
search community, only 5% (US$ 6 million) of funding
for Service Delivery was dedicated to this intervention.
HSS overall
The majority of HSS funds are dedicated to disease-
specific interventions; this is in accordance with the
Global Fund’s ‘diagonal’ approach to HSS – strength-
ening the national health system using concretely-
targeted interventions [7]. There is also evidence of
significant system-level support without regard to any
of the three diseases, and this fact has been largely
neglected in the literature. It would be interesting to
compare these results to the investment profiles of
other Rounds to address a number of questions. Has
the percentage of system-level support increased over
time? Is this related to increased understanding of
systems thinking within the Global Fund Secretariat,
among the applicant countries, Country Coordinating
Mechanisms, and the consultants and technical agency
staff who write Global Fund proposals in many countries?
It would also be of interest to compare the HSS fundingcontained in the approved grants versus the rejected grants.
Is the Global Fund more likely to fund programs that in-
clude disease-specific or system-level HSS objectives?
As discussed, within the portion of resources allocated
to HSS, the activities can be further divided into the
WHO-defined building blocks. It is immediately appar-
ent that the majority of activity is within the three more
‘concrete’ building blocks- Human Resources, Medicines
and Technology, and Service Delivery, as these three cat-
egories are easier to measure in terms of need, out-
comes, and performance. On the other hand, the results
achieved through investments in Governance, Financing,
and Information are inherently much more difficult to
evaluate; of course, within in each there are concrete
functions and interventions. As discussed in the previous
sections, the concrete interventions were more likely to
be funded rather than the more complex, yet arguably
more important, interventions operational at the inter-
face of the building blocks. Based on the evidence of
this phenomenon, it can be presumed that donors
and recipients are both likely to feel more comfort-
able with ‘concrete’ investments, especially in terms of
the performance-based funding approach of the Glo-
bal Fund.
A system-wide approach results in synergistic im-
provements in the system with perhaps a greater balance
amongst all six building blocks [9]. It is widely acknowl-
edged that the governance and health financing systems
of LMIC are relatively weak, and this is mirrored in the
lack of funding for interventions in these building
blocks. Greater awareness, by both funders and recipi-
ents, is required for the intervention innovation neces-
sary for strengthening. GHIs should partner with
members of the academic community to develop a book
on best practices which promotes operational interven-
tions across the health system and emphasizes the po-
tential returns of investment in the largely neglected
building blocks.
It would be interesting to perform this analysis on
Phase II of Round 8. Are the ‘concrete’ building blocks
still over-represented, or have the recipients shifted their
focus to Governance, Financing, and Information once
they are less accountable for the immediate, concrete re-
sults needed when requesting a continuation of funds
and concerned more with developing sustainable health
systems?
Conclusions
This study addresses concerns in the research and develop-
ment community that the Global Fund does not sufficiently
contribute resources to health systems strengthening.
Our results show a substantial portion (approximately
37%; more than US$ 460 million) of the Global Fund
Round 8 funds were devoted to HSS, and of this, 38%
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system-level interventions and 62 percent (approximately
US$ 223 million) dedicated to system-level interventions
for the target diseases. The Service Delivery, Medicines
and Technology, and Human Resources building blocks
received the most support with 31, 28, and 23% of the
HSS funds (US$ 112 million, 101 million, and 82 million);
respectively. Information, Governance, and Financing
combined received 18% of the HSS funds (12, 5, and 1%
(US$ 44 million, 19 million, and 4 million) ; respectively).
Within each building block there was significant skewing
towards only one or two major interventions.
Furthermore, this study highlights that the Global
Fund finances a diverse set of HSS activities among re-
cipients, even within a building block. The lack of
activity-prescription by the Global Fund allows for more
personalized and creative interventions. But the dramatic
skewing among the building blocks suggests that the
Global Fund needs to explicitly define what they are
willing to fund within the Governance, Financing, and
Information building blocks. Either the request for funds
in these areas is rejected by the Global Fund, or aware-
ness by the Recipients is lacking. Either way, the Global
Fund, and potentially other GHIs providing HSS
funding, needs to explicitly defined interventions that
address these gaps while adhering to their mandate.
Of utmost importance as we move towards the dead-
line for the Millennium Development Goals, is the con-
sensus of international donors upon the meaning of
health system strengthening in the context of aid organi-
zations. Although the discrepancies in approach and def-
inition provoke continued reappraisal, crucial to scholarly
and policy discussion, a clear definition will help better
inform funding allocations by GHIs. The community
needs also to decide how to harmonize efforts among
agencies and with countries. There should be open com-
munication between the recipient country and all donors
to enhance the potential synergies between system-level
interventions. Ideally these discussions will then also lead
to an agreed-upon framework with which to evaluate HSS
efforts across GHI boundaries.
There is also a need for agreement, by researchers, re-
cipients, and donors, on keystone interventions that
have the greatest system-level impacts for the cost-
effective use of funds. This and other retrospective stud-
ies are most useful when utilized for determining past
efforts and future directions. It is necessary to under-
stand the patterns of HSS spending within each recipient
country when deciding how to proceed. Perhaps many
have focused enough effort on their health sector infra-
structure, e.g. transportation, technology and equipment,
and modernizing facilities, to safely divert their attention
to strengthening systems for which the infrastructure
was developed. There is always space for creativity whendeveloping and implementing system-level interventions;
with this comes risk but even greater potential rewards.
Reaching the Millennium Development Goals requires
an intensified focus on strengthening health systems. Ef-
fective health system strengthening depends on inter-
agency consensus and country commitment along with
concerted partnership.
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